Blue Fin Group, an IntegriChain Company

Don't miss your chance to gain valuable insights into the future of pharma! Join us at Informa Trade and Channel Strategies 2024. William Roth will deliver a keynote address on December 10th regarding the latest trends and challenges shaping the industry. Use code 24INTEGRI10 for 10% off your registration fee. Learn more: https://lnkd.in/e25ABu5G

Bruce Phelan is a valued leader of our strategic consulting team! Bruce has extensive experience in the specialty product, cell and gene, precision medicine, protein, monoclonal and blood-product markets, with a focus on commercialization strategy, product portfolio management, site of care delivery logistics, and patient support services for complex therapies. He applies his analytic and strategic approach to market and delivery challenges when launching, optimizing, and maintaining conventional and specialty product therapies in a variety of healthcare settings. We are lucky to have him on our team. If you're seeking to be part of a team that values its members, explore our career opportunities here: https://lnkd.in/d6B_eKm.

We’re thrilled to share the story of?Tim Murdoch, IntegriChain’s new Chief Commercial Officer, who brings a wealth of experience from his time with industry giants like Adobe, Salesforce, and SAP. As he joins us in our mission to transform pharma commercialization, Tim reflects on the journey from tech leaders to an industry deeply focused on patient access and net revenue optimization. Read more about Tim’s vision for the future of pharma commercialization and his transition into pharma commercialization in our latest blog post: https://lnkd.in/eudxA6CM

??Access Insights 2024 Coverage ?? Bill Roth, General Manager, Managing Partner, Blue Fin Group, an IntegriChain Company, discusses key takeaways of the breakout session. IntegriChain

This year's Access Insights Conference produced record-breaking turnout and was chocked full of outstanding thought leadership on all things access and commercialization. We're so grateful to everyone who attended, participated, and sponsored our incredible event. ?? As we reflect on this year's conference, we're excited to announce that the Access Insights Conference 2025 is already in the works! Mark your calendars for October 27-29 at the Mayflower Hotel in Washington, D.C. We can't wait to bring you even more groundbreaking insights and networking opportunities.

So enjoyed hosting this outstanding panel of Chris Mancill Thomas Cohn and John Robicsek on Day 2 of the IntegriChain Access Insights Conference (it just gets more informative and thought provoking every year!) They provided perspectives of manufacturers, service providers and health systems on the potential changes to healthcare by 2030, the economic impacts on different stakeholders and how organizations are thinking about and preparing for those changes.

??Access Insights 2024 Coverage The Access Insights Conference carried on, and in his session on “Healthcare Policy Interpretation: Mapping Out the Third, Fourth, and Fifth Moves on the Chessboard,” Jeffrey Baab, partner, advisory services, IntegriChain, aimed to describe how the latest healthcare policies are impacting the industry. Blue Fin Group, an IntegriChain Company Federal Compliance Solutions, an IntegriChain Company

??Access Insights 2024 Coverage The conference’s opening keynote sets the scene for 2025 and the years to come. Blue Fin Group, an IntegriChain Company IntegriChain Federal Compliance Solutions, an IntegriChain Company

Day two of our Access Insights Conference is underway! This morning Katie Herrick and Dan DiGiorno discussed the major trends impacting physical access and affordability. We then heard from our expert panel, Michael Zubey, Lauren Labik, Ryan Moog, and Jordan W., as they shared their insights on enhancing market access and commercial effectiveness through patient data. We're looking forward to more insightful conversations.

“The information I'm going present to you guys this afternoon is not rosy. We’re not in a good spot as an industry,” he said. “There are lot businesses that are in pain right now. I was really focused on this concept of pain and the concept of community, and I think that's why I'm really appreciative that Joshua Halpern, our CEO, makes this happen every year—this is only about thought leadership." I think this quote sums up William Roth's character best - he takes a caring yet honest approach as he dove into the state of our financial climate, while looking ahead. Pharmaceutical Commerce Magazine Blue Fin Group, an IntegriChain Company IntegriChain Federal Compliance Solutions, an IntegriChain Company https://lnkd.in/eJvA-B6z